Guardant Health, Inc.
GH
$46.17
$1.984.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.95% | 20.76% | 30.16% | 33.87% | 29.23% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.95% | 20.76% | 30.16% | 33.87% | 29.23% |
| Cost of Revenue | 12.13% | 14.44% | 24.12% | 29.29% | 34.49% |
| Gross Profit | 43.95% | 24.76% | 34.24% | 36.96% | 25.82% |
| SG&A Expenses | 39.00% | 26.75% | 34.51% | 39.83% | 8.71% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.88% | 17.15% | 21.95% | 20.33% | 8.23% |
| Operating Income | -5.85% | -11.04% | -10.83% | -3.23% | 15.92% |
| Income Before Tax | 2.57% | 17.20% | 41.21% | -25.83% | -41.81% |
| Income Tax Expenses | -71.43% | -28.40% | 232.35% | -93.88% | -73.19% |
| Earnings from Continuing Operations | 2.66% | 17.24% | 40.65% | -25.15% | -41.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.66% | 17.24% | 40.65% | -25.15% | -41.03% |
| EBIT | -5.85% | -11.04% | -10.83% | -3.23% | 15.92% |
| EBITDA | -7.19% | -12.90% | -12.37% | -4.01% | 17.46% |
| EPS Basic | 3.96% | 18.68% | 43.17% | -19.75% | -25.31% |
| Normalized Basic EPS | -13.38% | -4.06% | -9.48% | 0.39% | 31.44% |
| EPS Diluted | 3.96% | 18.68% | 43.17% | -19.75% | -25.31% |
| Normalized Diluted EPS | -13.38% | -4.06% | -9.48% | 0.39% | 31.44% |
| Average Basic Shares Outstanding | 1.36% | 1.77% | 4.43% | 4.51% | 12.53% |
| Average Diluted Shares Outstanding | 1.36% | 1.77% | 4.43% | 4.51% | 12.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |